Hypertrophic obstructive cardiomyopathy: review of surgical treatment

Jonathan Price, Nicholas Clarke, Aslan Turer, Eduard Quintana, Carlos Mestres, Lynn Huffman, Matthias Peltz, Michael Wait, W. Steves Ring, Michael Jessen, Pietro Bajona

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Hypertrophic cardiomyopathy ranks among the most common congenital cardiac diseases, affecting up to 1 in 200 of the general population. When it causes left ventricular outflow tract obstruction, treatment is guided to reduce symptoms and the risk of sudden cardiac death. Pharmacologic therapy is the first-line treatment, but when it fails, surgical myectomy or percutaneous ablation of the hypertrophic myocardium are the standard therapies to eliminate subaortic obstruction. Both surgical myectomy and percutaneous ablation are proven safe and effective treatments; however, myectomy is the gold standard with a significantly lower complication rate and more complete and lasting reduction of left ventricular outflow tract obstruction.

Original languageEnglish (US)
Pages (from-to)594-607
Number of pages14
JournalAsian Cardiovascular and Thoracic Annals
Issue number9
StatePublished - Nov 1 2017


  • Ablation techniques
  • Cardiomyopathy
  • Heart septum
  • Mitral valve
  • Ventricular function
  • Ventricular outflow obstruction
  • hypertrophic
  • left

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Hypertrophic obstructive cardiomyopathy: review of surgical treatment'. Together they form a unique fingerprint.

Cite this